Clinical trial

Pilot Study of (MR) Imaging With Pyruvate (13C) to Detect High Grade Prostate Cancer

NCT02526368

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2016-03-22

PhaseEARLY_PHASE1

Study timeline

Study start (actual)2016-03-22Date precision: day

Registry last updated2026-04-30

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Prostate Cancerunresolved

Localized Prostate Carcinomaunresolved

Interventions

Hyperpolarized 13C-PyruvateDRUG

Hyperpolarized 13C,15N2-ureaDRUG

Magnetic Resonance Spectroscopic ImagingPROCEDURE

Sponsors & collaborators

Ivan de Kouchkovsky, MDlead sponsor

American Cancer Society, Inc.collaborator

National Cancer Institute (NCI)collaborator

National Institute for Biomedical Imaging and Bioengineering (NIBIB)collaborator

Mapped research locations

San FranciscoCalifornia, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02526368 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.